ING Groep NV Invests $442,000 in Becton Dickinson and Co. (BDX)
ING Groep NV acquired a new position in Becton Dickinson and Co. (NYSE:BDX) during the second quarter, Holdings Channel reports. The fund acquired 2,603 shares of the company’s stock, valued at approximately $442,000.
Several other hedge funds and other institutional investors also recently modified their holdings of BDX. Bank of Montreal Can bought a new position in shares of Becton Dickinson and during the second quarter worth approximately $118,746,000. UBS Group AG boosted its position in shares of Becton Dickinson and by 52.8% in the first quarter. UBS Group AG now owns 1,345,361 shares of the company’s stock worth $204,253,000 after buying an additional 464,650 shares in the last quarter. Bellevue Group AG bought a new position in shares of Becton Dickinson and during the first quarter worth approximately $15,216,000. AXA boosted its position in shares of Becton Dickinson and by 18.8% in the first quarter. AXA now owns 348,007 shares of the company’s stock worth $52,835,000 after buying an additional 55,178 shares in the last quarter. Finally, First Quadrant L P CA bought a new position in shares of Becton Dickinson and during the second quarter worth approximately $8,598,000. Institutional investors own 81.96% of the company’s stock.
Shares of Becton Dickinson and Co. (NYSE:BDX) traded up 1.01% during trading on Monday, reaching $179.19. The company had a trading volume of 431,974 shares. The firm has a 50-day moving average of $176.38 and a 200-day moving average of $168.90. The company has a market cap of $38.15 billion, a P/E ratio of 34.20 and a beta of 0.93. Becton Dickinson and Co. has a 12-month low of $129.50 and a 12-month high of $181.76.
Becton Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, August 4th. The company reported $2.35 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.21 by $0.14. Becton Dickinson and had a net margin of 9.24% and a return on equity of 24.26%. The company earned $3.20 billion during the quarter, compared to analysts’ expectations of $3.21 billion. During the same period in the prior year, the company earned $2.05 earnings per share. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. On average, equities research analysts anticipate that Becton Dickinson and Co. will post $8.56 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, September 30th. Investors of record on Friday, September 9th were paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 1.47%. The ex-dividend date of this dividend was Wednesday, September 7th. Becton Dickinson and’s payout ratio is presently 50.19%.
A number of research analysts have commented on BDX shares. Citigroup Inc. cut Becton Dickinson and from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $167.00 to $165.00 in a research note on Friday, September 23rd. Bank of America Corp. reiterated a “buy” rating on shares of Becton Dickinson and in a research note on Tuesday, July 12th. Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a research note on Tuesday, August 16th. Jefferies Group reiterated a “buy” rating on shares of Becton Dickinson and in a research note on Friday, August 5th. Finally, Leerink Swann reiterated a “hold” rating on shares of Becton Dickinson and in a research note on Tuesday, August 9th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Becton Dickinson and has a consensus rating of “Buy” and a consensus price target of $170.82.
In related news, insider Gary M. Cohen sold 29,367 shares of the stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $176.81, for a total value of $5,192,379.27. Following the completion of the sale, the insider now owns 125,870 shares in the company, valued at $22,255,074.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Linda M. Tharby sold 11,704 shares of the stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the sale, the insider now owns 22,146 shares of the company’s stock, valued at approximately $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
Becton Dickinson and Company Profile
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.